PLAY PODCASTS
Pure Global: Brazil's Clinical Trial Overhaul - The MedTech Insider's Playbook

Pure Global: Brazil's Clinical Trial Overhaul - The MedTech Insider's Playbook

LATAM MedTech Insights · Ran Chen

December 9, 20252m 18s

Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

This week on LATAM MedTech Insights, we're diving into a groundbreaking regulatory shift in Brazil. For years, launching a clinical trial in Latin America's largest market was a high-risk gamble due to unpredictable and lengthy approval processes. Now, everything has changed. A new Clinical Research Statute is dismantling these old barriers, aiming to slash approval times and make Brazil a global hub for MedTech innovation. We explore the concrete changes to the ethics review system and what this means for international companies that had previously put their Brazilian market entry plans on hold. A U.S. MedTech startup with a novel cardiovascular device had to shelve its plans to enter Brazil because of the dreaded 18-month approval delays, which threatened their investment timeline. Now, the new law presents a clear, predictable path to starting their clinical trial in under six months, completely changing their strategic calculus for the LATAM region. This Episode’s Key Takeaways: - Why was Brazil’s old clinical trial system a major roadblock for MedTech innovators? - How exactly does the new Clinical Research Statute reduce approval timelines? - What is the role of the new INEP ethics board, and how does it differ from the old system? - Are the responsibilities for trial sponsors now easier to manage in Brazil? - What immediate steps should a foreign MedTech company take to leverage this new regulation? - Is Brazil poised to become the new leader for clinical research in Latin America? - What are the hidden risks or remaining challenges in this new regulatory environment? At Pure Global, we offer end-to-end regulatory consulting solutions to help MedTech and IVD companies navigate complex markets like Brazil. We combine local expertise with advanced AI and data tools to streamline global market access, from initial strategy and technical dossier submission to post-market surveillance. Let us be your local representative and strategic partner in over 30 markets worldwide. To turn these insights into your market success story, contact us at [email protected] or visit https://pureglobal.com/.